Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alkala N
- Development stage
- Unknown
- Lead developer
- Sanum-Kehlbeck
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Alkala N is a dietary supplement developed by Sanum-Kehlbeck designed to regulate the body's acid-base balance. It is formulated as an oral powder containing a combination of alkaline salts, including sodium bicarbonate, potassium bicarbonate, and sodium citrate, which function as physiological buffers to neutralize excess acidity. The product also includes zinc gluconate, which contributes to the maintenance of normal skin, hair, nails, and eyesight. Unlike molecularly targeted pharmaceuticals, Alkala N works through general chemical buffering to support metabolic pH homeostasis and is categorized as a preparation for base regulation within Sanum therapy.
- Brand names
- Alkala N
- Other names
- Alkala "N"
Beyond the preview
Go deeper on Alkala N.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Alkala N.